General Information of the Compound
| Compound ID |
CP0445829
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1R,6R,8S,11S,13S,16R,17R)-8-tert-butyl-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-6,17-diol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H30O6
|
||||||||||||||||||
| Molecular Weight |
366.454
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1CO[C@H]2C[C@@]34C5C[C@@H](C(C)(C)C)C33[C@@H](O)COC3O[C@]4(CO5)[C@@]12O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H30O6/c1-10-7-23-14-6-17-13-5-11(16(2,3)4)19(17)12(21)8-24-15(19)26-18(17,9-25-13)20(10,14)22/h10-15,21-22H,5-9H2,1-4H3/t10-,11+,12+,13?,14+,15?,17+,18+,19?,20-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QCNOIYKETTUWMH-UTIXZKKXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05068, Glycine receptor subunit alpha-1
Protein ID: PT06069, Glycine receptor subunit alpha-2